- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07816003
Machine Learning Prediction of Spinal Anaesthesia Block Duration
September 7, 2026 updated by: SalahEldin Ahmed Abdelaziz Ahmed, Specialized Medical Center (SMC)
Artificial Intelligence-Based Prediction of Sensory and Motor Block Duration Following Spinal Anaesthesia: A Prospective Observational Prediction Model Development Study
The duration of sensory and motor block after spinal anaesthesia varies widely between patients given the same dose of local anaesthetic.
Much of this variability is explained by differences in lumbosacral cerebrospinal fluid volume, which cannot be measured routinely in clinical practice but is related to simple body measurements such as abdominal circumference and vertebral column length.
This prospective observational study will develop and internally validate prediction models for the duration of sensory and motor block following spinal anaesthesia in adults undergoing elective surgery.
Preoperative clinical and anthropometric variables will be recorded, and block regression will be assessed serially after intrathecal injection.
Machine learning methods (lasso regression, ridge regression, random forest, extreme gradient boosting, and support vector regression) will be developed and compared against multivariable linear regression as the reference model.
The aim is a practical tool that helps anaesthetists anticipate how long a spinal block will last in an individual patient, supporting decisions about case scheduling, supplementation, and discharge planning.
Study Overview
Status
Not yet recruiting
Detailed Description
Background.
Spinal anaesthesia produces block of unpredictable duration.
Cerebrospinal fluid volume in the lumbosacral region is the dominant determinant of block spread and regression, and correlates inversely with abdominal circumference and directly with vertebral column length.
Existing single-variable rules perform poorly, and no validated multivariable model is in routine clinical use.
Objectives.
The primary objective is to develop and internally validate models predicting the duration of sensory block and the duration of motor block after single-shot spinal anaesthesia.
The secondary objective is to compare the predictive performance of machine learning approaches with conventional multivariable linear regression.
Design.
Single-centre prospective observational cohort study.
No study-directed intervention is applied; anaesthetic technique, drug, and dose are determined by the attending anaesthetist according to routine practice and are recorded as candidate predictors.
Assessments.
Sensory block level is assessed bilaterally by pinprick with a 25-gauge needle along the mid-clavicular line, over dermatomes T4 to S1. Motor block is assessed using the modified Bromage scale (0-3).
Assessments are performed at fixed intervals from intrathecal injection until complete regression of sensory and motor block.
Candidate predictors.
Age, sex, height, weight, body mass index, abdominal circumference, vertebral column length, ASA physical status, local anaesthetic dose and baricity, and adjuvant use.
Sample size.
A target of 255 participants was derived using the Riley criteria for continuous-outcome prediction models (pmsampsize), assuming 9 candidate predictors, an outcome standard deviation of 40 minutes, anticipated R-squared of 0.35, shrinkage of at least 0.90, and a multiplicative margin of error of 1.10.
The four criteria yielded 183, 183, 234, and 246; the largest requirement of 246 was inflated by approximately 4 per cent for attrition.
Analysis.
Model development will use nested repeated 10-fold cross-validation with bootstrap optimism correction.
Performance will be reported as R-squared, root mean squared error, and mean absolute error, with calibration plots.
SHAP values will be used to describe predictor contributions.
Reporting will follow TRIPOD+AI.
Study Type
Observational
Enrollment (Estimated)
255
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Salaheldin A Abdelaziz Ahmed
- Phone Number: +966508818713
- Email: saladin28.sa@gmail.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Consecutive adults scheduled for elective surgery under single-shot spinal anaesthesia at Specialized Medical Center, King Fahad campus, Riyadh.
Description
Inclusion Criteria:
- Adults scheduled for elective surgery under single-shot spinal anaesthesia ASA physical status I to III Written informed consent obtained
Exclusion Criteria:
- Contraindication to neuraxial anaesthesia (coagulopathy, local or systemic infection, raised intracranial pressure, patient refusal) Failed or incomplete block requiring conversion to general anaesthesia Repeated or top-up intrathecal injection Pregnancy Known spinal deformity or previous spine surgery Pre-existing neurological or neuromuscular disease affecting sensory or motor assessment Inability to cooperate with sensory and motor assessment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Duration of sensory block
Time Frame: Up to 8 hours after intrathecal injection
|
Time from completion of intrathecal injection to regression of sensory block to the S1 dermatome, assessed bilaterally by pinprick with a 25-gauge needle along the mid-clavicular line
|
Up to 8 hours after intrathecal injection
|
|
Duration of motor block
Time Frame: Up to 8 hours after intrathecal injection
|
Time from completion of intrathecal injection to return to modified Bromage score 0 (full ability to flex knee and ankle)
|
Up to 8 hours after intrathecal injection
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Predictive performance of machine learning models
Time Frame: Through study completion, an average of 20 months
|
R-squared, root mean squared error, mean absolute error, and calibration slope for lasso regression, ridge regression, random forest, extreme gradient boosting, and support vector regression, each compared with multivariable linear regression as the reference model
|
Through study completion, an average of 20 months
|
|
Time to peak sensory block level
Time Frame: Up to 30 minutes after intrathecal injection
|
Time from intrathecal injection to the highest dermatomal level of sensory block, assessed by pinprick
|
Up to 30 minutes after intrathecal injection
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Salaheldin A abdelaziz Ahmed, Specialized Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
December 1, 2026
Primary Completion (Estimated)
July 1, 2028
Study Completion (Estimated)
September 1, 2028
Study Registration Dates
First Submitted
September 7, 2026
First Submitted That Met QC Criteria
September 7, 2026
First Posted (Actual)
September 11, 2026
Study Record Updates
Last Update Posted (Actual)
September 11, 2026
Last Update Submitted That Met QC Criteria
September 7, 2026
Last Verified
September 1, 2026
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IRBSMC1-2026-0001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
De-identified individual participant data underlying published results, together with the data dictionary and model code, will be made available to researchers whose proposed use has been approved by an independent review committee.
Requests should be directed to the principal investigator.
Data will be available from 6 months to 36 months after publication of the primary results.
IPD Sharing Time Frame
Data will become available 6 months after publication of the primary results and will remain available for 36 months
IPD Sharing Access Criteria
Requests should be directed to the principal investigator.
Proposals will be reviewed by the principal investigator and the Specialized Medical Center Institutional Review Board.
Requesters must provide a methodologically sound proposal and sign a data access agreement.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.